Although levels of serum chemerin have varied across studies of patients with systemic sclerosis ([51,52]), with results depending on duration and disease involvement (diffuse versus limited), no consistent findings of differences in chemerin expression have been identified in patients with systemic sclerosis and concomitant interstitial lung disease and those without ILD. Here, RARRES2 is linked to systemic sclerosis.